173 related articles for article (PubMed ID: 2456930)
1. Acute vascular toxicity after combination chemotherapy with cisplatin, vinblastine, and bleomycin for testicular cancer.
Stefenelli T; Kuzmits R; Ulrich W; Glogar D
Eur Heart J; 1988 May; 9(5):552-6. PubMed ID: 2456930
[TBL] [Abstract][Full Text] [Related]
2. Raynaud's phenomenon: a common toxicity after combination chemotherapy for testicular cancer.
Vogelzang NJ; Bosl GJ; Johnson K; Kennedy BJ
Ann Intern Med; 1981 Sep; 95(3):288-92. PubMed ID: 6168223
[TBL] [Abstract][Full Text] [Related]
3. Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer.
Berger CC; Bokemeyer C; Schneider M; Kuczyk MA; Schmoll HJ
Eur J Cancer; 1995 Dec; 31A(13-14):2229-38. PubMed ID: 8652248
[TBL] [Abstract][Full Text] [Related]
4. Raynaud's phenomenon as a side effect of chemotherapy with vinblastine and bleomycin for testicular carcinoma.
Teutsch C; Lipton A; Harvey HA
Cancer Treat Rep; 1977 Aug; 61(5):925-6. PubMed ID: 70274
[No Abstract] [Full Text] [Related]
5. Raynaud's phenomenon and cryoglobulinemia during chemotherapy for testicular carcinoma.
Dunlop PR; Hendy-Ibbs PM
Cancer Treat Rep; 1983 Mar; 67(3):317-8. PubMed ID: 6187453
[No Abstract] [Full Text] [Related]
6. Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin.
Vogelzang NJ; Torkelson JL; Kennedy BJ
Cancer; 1985 Dec; 56(12):2765-70. PubMed ID: 2413982
[TBL] [Abstract][Full Text] [Related]
7. Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis.
Doll DC; List AF; Greco FA; Hainsworth JD; Hande KR; Johnson DH
Ann Intern Med; 1986 Jul; 105(1):48-51. PubMed ID: 2424354
[TBL] [Abstract][Full Text] [Related]
8. Raynaud's phenomenon after vinblastine-bleomycin chemotherapy.
Rothberg H; Varney JK
J Med Soc N J; 1978 Nov; 75(12):845-6. PubMed ID: 81878
[No Abstract] [Full Text] [Related]
9. [Raynaud's disease after treatment with bleomycin and vinblastine].
Dzieza-Lalowicz I; Mykała-Cieśla J
Pol Tyg Lek; 1986 Feb; 41(7):218-9. PubMed ID: 2423995
[No Abstract] [Full Text] [Related]
10. Raynaud's phenomenon after vinblastine-bleomycin chemotherapy.
Rothberg H
Cancer Treat Rep; 1978 Apr; 62(4):569-70. PubMed ID: 77726
[No Abstract] [Full Text] [Related]
11. [Raynaud's phenomenon following combined cytostatic treatment of malignant testicular tumours].
Scheulen ME; Schmidt CG
Dtsch Med Wochenschr; 1982 Oct; 107(43):1640-4. PubMed ID: 6183087
[TBL] [Abstract][Full Text] [Related]
12. High-dose versus low-dose vinblastine in cisplatin-vinblastine-bleomycin combination chemotherapy of non-seminomatous testicular cancer: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group.
Stoter G; Sleyfer DT; ten Bokkel Huinink WW; Kaye SB; Jones WG; van Oosterom AT; Vendrik CP; Spaander P; de Pauw M; Sylvester R
J Clin Oncol; 1986 Aug; 4(8):1199-206. PubMed ID: 2426419
[TBL] [Abstract][Full Text] [Related]
13. Reduced platelet survival following chemotherapy with vinblastine, bleomycin and cis-platinum for testicular teratoma.
Rees GJ; Slade RR; Hopes P
Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1125-9. PubMed ID: 6186497
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of long-term toxicity after chemotherapy for testicular cancer.
Bokemeyer C; Berger CC; Kuczyk MA; Schmoll HJ
J Clin Oncol; 1996 Nov; 14(11):2923-32. PubMed ID: 8918489
[TBL] [Abstract][Full Text] [Related]
15. Vinblastine, cisplatin and bleomycin (VPB) adjuvant therapy does not induce dose-dependent damage in human chromosomes.
Gundy S; Baki M; Bodrogi I
Neoplasma; 1989; 36(4):457-64. PubMed ID: 2475796
[TBL] [Abstract][Full Text] [Related]
16. Angina pectoris following cisplatin, etoposide, and bleomycin in a patient with advanced testicular cancer.
Rodriguez J; Collazos J; Gallardo M; Hernando G
Ann Pharmacother; 1995 Feb; 29(2):138-9. PubMed ID: 7538830
[TBL] [Abstract][Full Text] [Related]
17. Bleomycin-vinblastine associated Raynaud's phenomenon.
Paty JG; Ruffner BW
J Rheumatol; 1980; 7(6):927-8. PubMed ID: 6162955
[No Abstract] [Full Text] [Related]
18. Second malignancy after cisplatin, vinblastine, and bleomycin (PVB) chemotherapy: a case report.
Mead GM; Green JA; Macbeth FR; Williams CJ; Whitehouse JM; Buchanan R
Cancer Treat Rep; 1983 Apr; 67(4):410. PubMed ID: 6189603
[No Abstract] [Full Text] [Related]
19. Combination cisplatin, vinblastine, and bleomycin chemotherapy (PVB) for malignant germ-cell tumors of the ovary.
Carlson RW; Sikic BI; Turbow MM; Ballon SC
J Clin Oncol; 1983 Oct; 1(10):645-51. PubMed ID: 6199468
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.
Bosl GJ; Geller NL; Bajorin D; Leitner SP; Yagoda A; Golbey RB; Scher H; Vogelzang NJ; Auman J; Carey R
J Clin Oncol; 1988 Aug; 6(8):1231-8. PubMed ID: 2457657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
